Clinical Trials Browser

OTHER × Dehydroepiandrosterone × Clear all

NCT07407647 2026-02-12

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05562518 2025-07-23

GRACE

Phase 4 Recruiting

Breast Neoplasms

NCT04493333 2024-11-27

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

Phase 2 Terminated

8 enrolled 11 charts

Vaginal Atrophy

NCT06611514 2024-11-19

PROPOSE

Phase 3 Not yet recruiting

Breast Neoplasms

NCT05263557 2023-07-25

DIMOXIS

Phase NA Unknown

Endocrine System Diseases, Insulin Resistance, Polycystic Ovary Syndrome

NCT05246865 2022-11-02

11OXO-PCOS

Phase NA Unknown

Polycystic Ovary Syndrome

NCT04705883 2022-02-22

VIBRA

Phase 4 Completed

Breast Neoplasms

NCT00972023 2019-09-17

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Phase 1 Terminated

1 enrolled 3 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02683148 2019-09-09

DHEA in Synovial Sarcoma Patients

Phase 1 Terminated

Sarcoma, Synovial

NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Phase 3 Completed

464 enrolled 8 charts

BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00516542 2012-07-24

Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer

Phase 1 Terminated

Breast Neoplasms, Breast Neoplasms, Male